The Genitourinary Malignancies Research Center focuses on advancing discoveries to better understand, diagnose and treat cancer of the prostate, bladder and kidney. The center is a cross-discipline partnership that will leverage Cleveland Clinic's research and clinical strengths to make practice-changing discoveries in GU cancers.More About Us
Multidisciplinary investigators in the Genitourinary Malignancies Research Center study cancers of the genitourinary system, with special emphasis on prostate, bladder and kidney cancer.Learn More
Latest novel finding adds to list of cancers associated with the HSD3B1 gene; clinical and research teams investigating potential connections.
Dr. Nima Sharifi and a team of researchers uncovered how tumors circumvent prostate cancer therapy and identified a potential window of time after treatment when tumors may be responsive to immunotherapy.
Dr. Sharifi and collaborators identified choline, betaine and phenylacetylglutamine as nutrients and gut microbiome metabolites associated with increased risk for lethal prostate cancer, suggesting dietary interventions may help reduce disease risk.